Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2014 · 10-Q
Revenue$4.89M$4.89M+0.7% vs Q2 2013 Net Income$215.77K$215.77KN/M vs Q2 2013 EPS Diluted$0.02$0.02N/M vs Q2 2013 Operating Income$562,330+533.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$405,946−5.7% Margins · derivedOperating margin11.5%+9.7 pt vs Q2 2013
Net margin4.4%+9.4 pt vs Q2 2013
ended May 31, 2014 · filed Jul 3, 2014 · 33 d after period end